Brief: Ascelia Pharma Q3 EBIT SEK -15.3 Million
05/11/2025 06:30
Nov 05 (Reuters) - Ascelia Pharma Q3 cash flow from operations SEK -15.7 million. Q3 EPS SEK -0.13
ACE — Ascelia Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK71.37m
- SEK33.84m
Last trade - 00:00